Yu Xiao
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Molecular Medicine top 1%
- Hydrogels: synthesis, properties, applications
Papers in
-
- RNA modifications and cancer 16
- Ubiquitin and proteasome pathways 14
- Epigenetics and DNA Methylation 12
-
- Cancer, Lipids, and Metabolism 24
- Cancer-related molecular mechanisms research 15
- Co-authors
- Xinghuan Wang (86 shared papers)Gang Wang (69 shared papers)Weikang Hu (5 shared papers)Zijian Wang (5 shared papers)Jianglin Wang (4 shared papers)Shengmin Zhang (3 shared papers)Kaiyu Qian (57 shared papers)Lingao Ju (54 shared papers)
- Journals
- International Journal of Biological Sciences (10 papers)Journal of Cancer (7 papers)Cancer Cell International (7 papers)Frontiers in Oncology (6 papers)Cell Death and Disease (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yu Xiao
198 papers receiving 6.0k citations
Yu Xiao's Hit Papers
Peers
Comparison fields: 5 of 157
- Cancer Research 1.1k
- Molecular Medicine 315
- Biomaterials 568
- Rehabilitation 198
- Infectious Diseases 550
Countries citing papers authored by Yu Xiao
This map shows the geographic impact of Yu Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Xiao more than expected).
Fields of papers citing papers by Yu Xiao
This network shows the impact of papers produced by Yu Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Xiao. The network helps show where Yu Xiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 213 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advances in crosslinking strategies of biomedical hydrogels Hit paper breakdown → | 2018 | 703 |
| 2 | Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China Hit paper breakdown → | 2020 | 656 |
| 3 | 2014 | 205 | |
| 4 | 2020 | 116 | |
| 5 | 2016 | 108 | |
| 6 | 2016 | 107 | |
| 7 | 2004 | 105 | |
| 8 | 2017 | 96 | |
| 9 | 2019 | 92 | |
| 10 | 2020 | 83 | |
| 11 | 2022 | 81 | |
| 12 | 2020 | 79 | |
| 13 | 2018 | 78 | |
| 14 | 2009 | 72 | |
| 15 | 2017 | 70 | |
| 16 | 2018 | 70 | |
| 17 | 2017 | 69 | |
| 18 | 2017 | 65 | |
| 19 | 2018 | 63 | |
| 20 | 2018 | 61 |
About Yu Xiao
Yu Xiao is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 213 papers that have together received 6.1k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (27 papers), Cancer, Lipids, and Metabolism (24 papers), Bladder and Urothelial Cancer Treatments (19 papers), RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (15 papers), Ubiquitin and proteasome pathways (14 papers), Renal cell carcinoma treatment (14 papers) and Epigenetics and DNA Methylation (12 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Medicine (315 citations), Biomaterials (568 citations), Rehabilitation (198 citations) and Infectious Diseases (550 citations). Yu Xiao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xinghuan Wang, Gang Wang, Weikang Hu, Zijian Wang, Jianglin Wang, Shengmin Zhang, Kaiyu Qian, Lingao Ju, Guofeng Qian and Lushun Yuan. Their work appears in journals such as International Journal of Biological Sciences, Journal of Cancer, Cancer Cell International, Frontiers in Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.